NASDAQ:PRTC PureTech Health (PRTC) Stock Price, News & Analysis → Hurry! Buy this stock before the Robinhood traders do! (From Traders Agency) (Ad) Free PRTC Stock Alerts $29.92 -1.08 (-3.48%) (As of 06/4/2024) Add Compare Share Share Today's Range$29.92▼$29.9250-Day Range$25.48▼$31.3052-Week Range$17.08▼$34.00Volume300 shsAverage Volume3,585 shsMarket Capitalization$809.04 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Get PureTech Health alerts: Email Address Ad Porter & CompanyHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future.Click here to watch this now before it’s too late. About PureTech Health Stock (NASDAQ:PRTC)PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies. It also develops SPT-300, an oral drug of allopregnanolone for the treatment of anxious depression; SPT-320, a novel prodrug of agomelatine for the treatment of generalized anxiety disorder; and SPT-348, a prodrug of a non-hallucinogenic neuroplastogen for the treatment of mood and other neuropsychiatric disorders. In addition, the company is developing hydrogels to enable the oral administration of peptide therapeutics in preclinical development. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.Read More PRTC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PRTC Stock News HeadlinesJune 2, 2024 | americanbankingnews.comPureTech Health (NASDAQ:PRTC) Shares Gap Up to $30.17June 1, 2024 | americanbankingnews.comPureTech Health (NASDAQ:PRTC) Hits New 12-Month High at $34.28May 29, 2024 | businesswire.comPureTech Founded Entity Akili Interactive and Virtual Therapeutics Announce Entering Into Definitive Merger Agreement to Establish Leading Digital Health CompanyMay 23, 2024 | businesswire.comPureTech to Present at the Jefferies Global Healthcare ConferenceMay 21, 2024 | businesswire.comPureTech Founded Entity Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile InfectionMay 20, 2024 | finanznachrichten.dePureTech Health plc: PureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary ShareMay 20, 2024 | businesswire.comPureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary ShareApril 27, 2024 | seekingalpha.comPureTech Health plc (PRTC) Q4 2023 Earnings Call TranscriptApril 25, 2024 | finance.yahoo.comPureTech Announces Annual Results for Year Ended December 31, 2023April 18, 2024 | businesswire.comPureTech Health: Notice of ResultsApril 16, 2024 | finance.yahoo.comPureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary FibrosisApril 11, 2024 | lse.co.ukUS FDA hands fast track to PureTech head and neck cancer treatmentApril 11, 2024 | markets.businessinsider.comPureTech's LYT-200 Receives FDA Fast Track Designation For Treatment Of Head & Neck CancersApril 11, 2024 | businesswire.comPureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck CancersApril 9, 2024 | businesswire.comPureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management TransitionsMarch 18, 2024 | businesswire.comBristol Myers Squibb Completes Acquisition of PureTech's Founded Entity Karuna Therapeutics for $14 BillionMarch 13, 2024 | finance.yahoo.comPureTech Receives Orphan Drug Designation for LYT-200 in Acute Myeloid LeukemiaFebruary 28, 2024 | finance.yahoo.comAKLI Mar 2024 3.000 callFebruary 27, 2024 | lse.co.ukPureTech notes positive results from Shionogi's EndeavorRx ADHD trialFebruary 27, 2024 | finance.yahoo.comPureTech to Present at Two Upcoming Investor ConferencesFebruary 27, 2024 | businesswire.comPureTech to Present at Two Upcoming Investor ConferencesFebruary 27, 2024 | finance.yahoo.comPureTech Founded Entity Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx ® for Pediatric ADHD Patients in JapanFebruary 27, 2024 | businesswire.comPureTech Founded Entity Akili Announces Positive Results from Shionogi's Phase 3 Clinical Trial of Localized Version of Akili's EndeavorRx ® for Pediatric ADHD Patients in JapanFebruary 22, 2024 | finance.yahoo.comPureTech Health plc (PRTC)February 15, 2024 | finance.yahoo.comDown -8.13% in 4 Weeks, Here's Why PureTech Health PLC Sponsored ADR (PRTC) Looks Ripe for a TurnaroundSee More Headlines Receive PRTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PureTech Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today6/09/2024Next Earnings (Estimated)7/25/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:PRTC CUSIPN/A CIK1782999 Webwww.puretechhealth.com Phone617-482-2333Fax617-482-3337Employees90Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio6.76 Quick Ratio6.76 Sales & Book Value Annual Sales$3.33 million Price / Sales242.95 Cash FlowN/A Price / Cash FlowN/A Book Value$16.94 per share Price / Book1.77Miscellaneous Outstanding Shares27,040,000Free Float25,608,000Market Cap$809.04 million OptionableNot Optionable Beta1.26 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesDr. Bharatt M. Chowrira J.D. (Age 59)Ph.D., CEO & Executive Director Comp: $2.19MMs. Daphne Zohar (Age 53)Founder, Senior Advisor & Board Observer Comp: $3.99MDr. Robert S. Langer Jr. (Age 75)Ph.D., Co-Founder & Non-Executive Director Comp: $135kDr. Eric Elenko Ph.D. (Age 51)President Dr. David R. Elmaleh Ph.D. (Age 76)Co-Founder & Senior Advisor Mr. Eric Green M.B.A.Chief Operating OfficerMs. Allison Mead TalbotHead of Communications & Investor RelationsMr. Charles Sherwood IIIJ.D., Ph.D., General Counsel & Company SecretaryMr. Spencer BallSenior Vice President of Human ResourcesMs. Aleksandra Filipovic M.D.Ph.D., Head of OncologyMore ExecutivesKey CompetitorsPrestige Consumer HealthcareNYSE:PBHArrowhead PharmaceuticalsNASDAQ:ARWRAmicus TherapeuticsNASDAQ:FOLDMerusNASDAQ:MRUSBiohavenNYSE:BHVNView All CompetitorsInstitutional OwnershipAWM Investment Company Inc.Bought 6,900 shares on 5/16/2024Ownership: 0.026%View All Institutional Transactions PRTC Stock Analysis - Frequently Asked Questions How have PRTC shares performed in 2024? PureTech Health's stock was trading at $28.18 on January 1st, 2024. Since then, PRTC shares have increased by 6.2% and is now trading at $29.92. View the best growth stocks for 2024 here. When is PureTech Health's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, July 25th 2024. View our PRTC earnings forecast. Who are PureTech Health's major shareholders? PureTech Health's stock is owned by a variety of retail and institutional investors. Top institutional investors include AWM Investment Company Inc. (0.03%). How do I buy shares of PureTech Health? Shares of PRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:PRTC) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | SponsoredNvidia needs this one obscure firm In my new investigation, I detail why this is the single most important factor in the future of AI. I expla...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PureTech Health plc Please log in to your account or sign up in order to add this asset to your watchlist. Share PureTech Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.